Leukotriene receptor antagonists

Topic: Pharmacology

Oral drugs that block receptors for leukotrienes, which cause bronchoconstriction, mucus and inflammation (e.g., montelukast); used as add-on controllers in asthma, for exercise-induced bronchospasm and, when other treatments fail, for allergic rhinitis, not for an acute attack. Serious neuropsychiatric effects such as agitation, sleep disturbance, depression and suicidal thinking have been reported. Teach daily use and keeping a rescue inhaler at hand, and ask the client and family to report mood or behavior changes at once.

Also known as:

LTRAs, Leukotriene modifiers, Montelukast

In Turkish:

Lökotrien reseptör antagonistleri